Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Recruiting now · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Von Willebrand Diseases
In brief
The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand Disease (VWD) and other bleeding disorders.
Key facts
- Study ID
- NCT05776069
- Run by
- Vega Therapeutics, Inc
- People needed
- 116
- Starts
- 2023-03-16
- Expected to finish
- 2029-12-01
- Last updated by the study team
- 2025-08-26
Who can join
Age: 12 and older, up to 60. Sex: any. Healthy volunteers: accepted.
Where it is running
- Imperial College Healthcare NHS Trust- Queen Charlotte's & Chelsea Hospital — London, United Kingdom (enrolling)
- UC Davis Medical Center — Sacramento, California, United States (enrolling)
- University of Colorado School of Medicine — Aurora, Colorado, United States (enrolling)
- Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory — Atlanta, Georgia, United States (enrolling)
- Science 37, Inc. — Morrisville, North Carolina, United States (enrolling)
- Hemophilia Center of Western PA — Pittsburgh, Pennsylvania, United States (enrolling)
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (enrolling)
- University of Texas Southwestern — Dallas, Texas, United States (enrolling)
- Washington Center for Bleeding Disorders — Seattle, Washington, United States (enrolling)
- Versiti Comprehensive Center for Bleeding Disorders — Milwaukee, Wisconsin, United States (enrolling)
- Royal Brisbane & Women's Hospital, Queensland Haemophilia Centre — Herston, Queenland, Australia (enrolling)
- Orthopedic Institute for Children (UCLA) — Los Angeles, California, United States (enrolling)
- Centro de Hemoterapia e Hematologia do Rio de Janeiro HEMORIO — Rio de Janeiro, Rio de Janeiro, Brazil (enrolling)
- Hemocentro Unicamp — Campinas, São Paulo, Brazil (enrolling)
- Hospital das Clinicas - USP Endereco — São Paulo, São Paulo, Brazil (enrolling)
- Hamilton Health Sciences Corporation — Hamilton, Ontario, Canada (enrolling)
- Queens University — Kingston, Ontario, Canada (enrolling)
- St. Michaels Hospital — Toronto, Ontario, Canada (enrolling)
- K J Somaiya Super Speciality Hospital & Research Centre — Sion, Mumbai, India (enrolling)
- Charlotte Maxeke Johannesburg Academic Hospital — Johannesburg, South Africa (enrolling)
- Queen Elizabeth Hospital Birmingham — Birmingham, Edgbaston, United Kingdom (enrolling)
- University Hospital Southampton NHS Foundation Trust — Southampton, Hampshire, United Kingdom (enrolling)
- Royal Free Hospital — London, London, United Kingdom (enrolling)
- Royal London Hospital, Clinical Haematology Research — Whitechapel, London, United Kingdom (enrolling)
- Medical University of Vienna — Vienna, State of Vienna, Austria
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.